The White House this week added AbbVie's Humira to its TrumpRx drug discount website, pricing the arthritis medication at $950 per month. The move places the brand-name drug on the same platform as cheaper biosimilar versions from Pfizer and Amgen.
Humira, one of the world's best-selling prescription drugs, has faced increased competition from biosimilar alternatives in recent years. The inclusion on TrumpRx represents the administration's continued effort to provide Americans with access to discounted prescription medications through a centralized platform.